Strokes in the elderly : Prevalence, risk factors and the strategies for prevention

Indian Journal of Medical Research

Volumn 106, Issue OCT., 1997, Pages 325-332

  Dalal, P M ^a,b  

^a LILAVATI HOSPITAL AND RESEARCH CENTRE   (India)

^b NONE   (India)

Author keywords

Cerebrovascular disease; Hypertension epidemiology; Risk factors in stroke; Stroke prevention; Strokes in elderly

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

AGED; BODY WEIGHT; DEMOGRAPHY; DIABETES MELLITUS; DIET; DISABILITY; EARLY DIAGNOSIS; FOLLOW UP; HEALTH CARE COST; HEALTH CARE PLANNING; HEMIPLEGIA; HUMAN; HYPERTENSION; INDIA; PATIENT COMPLIANCE; REVIEW; RISK; RISK FACTOR; SCREENING; SOCIOECONOMICS; STROKE; SURVIVAL; TOBACCO; TRANSIENT ISCHEMIC ATTACK; URBAN POPULATION;

AGED; CEREBROVASCULAR DISORDERS; HUMANS; INDIA; PREVALENCE; RISK FACTORS;

EID: 0030666512     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas A, Schroll M. Stroke incidence, case fatality and mortality in the W.H.O Monica Project. Stroke 1995; 361-7.
2. Dalal PM, Dalal KP. Cost and value of technical medicine for diagnosis and treatment of cerebrovascular disease - Problems in the developing countries. Jpn Heart J 1986; 27 : 901-10.
3. Heart and Stroke Facts, 1993 Statistical Supplement. American Heart Association, Dallas, Texas, 1993.
4. Dalal PM, Dalal K.P, Vyas AC. Strokes in the young population in west-central India - Some observations on changing trends in morbidity and mortality. Neuroepidemiology 1989; 8 : 160-4.
5. Thorn TJ. Stroke mortality trends : An international perspective. Ann Epidemiol 1993; 3 : 509-18.
6. Nencini P, Inzitari D, Baruffi MC et al. Incidence of stroke in young adults in Florence, Italy. Stroke 1988; 19 : 977-81.
7. Bonita R, Beaglehole R. The engima of the decline in stroke deaths in the United States - the search for an explanation. Stroke 1996; 27: 370-2.
8. Dalal PM, Dalal KP. Hypertension and stroke. In : Sainani GS, editor, Current concepts in hypertension, Indian College of Physicians, Bombay : Typo Graphics. 1995; 107-17.
9. Dalal PM. Strokes in young and elderly : risk factors and strategies for stroke prevention. JAPI 1997; 45 : 125-31.
10. Hatano S. Observer variations in the diagnosis of stroke : WHO collaborative study on the control of stroke in the Community. Jpn Heart J 1997; 18 : 171-7.
11. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community : results of a WHO collaborative study. Bull World Health Organ 1980; 58: 113-30.
12. Dalal PM, Dalal KP, Rao SV, Parikh BR. Strokes in west-central India : a prospective case-control study of 'risk factors' (A problem of developing countries). In : D. Bartko, F. Gerstenbrand. P. Turcani, editors. Neurology in Europe, London : John Libbey & Co. Ltd. 1989; 16-20.
13. Dalal PM et al. Low hemoglobin levels as a risk factor in cerebral infarction, (abstract) Stroke 1989; 20 : 157.
14. Gupta R. Meta-analysis of prevalence of hypertension in India. Indian Heart J 1997; 49 : 43-8.
15. Dalal PM. Community survey on high blood pressure in old Bombay. In : Essential hvpertension, RH Thurm, ed. Miami : Symposia Specialists, 1979; 35-41.
16. Briley DP, Coull BM, Goodnight SH. Neurological disease associated with antiphospholipid antibodies. Anal Neurol 1989; 25 : 221-7.
17. Dalal KP, Dalal PM, Desai BH. The anticardiolipin antibodies (ACA) in acute ischemic strokes Prospective case control study. Cerebrovasc Dis 1996; 6(52) : 101.
18. Chopra JS, Prabhkar SK. Clinical features and risk factors in strokes in young. Acta Neurol Scand 1979; 60 : 289-300.
19. Bansal BC, Prakash C, Arya RK, Gulati SK, Mittal SC. Serum lipids, platelets, and fibrinolytic activity in cerebrovascular disease. Stroke 1978; 9 : 137-9.
20. Sharma SC, Vijayan GP, Seth NH, Seth HN, Suri ML. Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in young patients with ischacmic stroke. J Neurol Neurosurg Psychiatry 1978; 41: 118-21.
21. Srinivasan K. Ischaemic cerebrovascular disease in the young : Two common causes in India. Stroke 1984; 15 : 733-5.
22. Abraham J. Cerebrovascular disorders in south India. In : Spillane JD, editor. Tropical neurology. London : Oxford University Press. 1973; 86-91.
23. Dalal PM, Dalal KP. Cerebrovascular manifestations of infectous diseases. In : Vinken PJ, Vinken GW, Klawaris HL, editors. Handbook of clinical neurology, Amsterdam: Elsevier Science Publishers, 1989; 11(55) : 411-41.
24. Bansal BC, Gupta RR, Prakash C. Stroke during pregnancy and puerperium in young females below the age of 40 years as a result of cerebral venous sinus thrombosis. Jpn Heart J 1980; 21 : 171-83.
25. Komachi Y, Iida M, Shimamoto T et al. Geographic and occupational comparisons of risk factors in cardiovascular diseases in Japan. Jpn Circ J 1971; 35 : 189-207.
26. Stamler J, Rose G, Stamler R. Elliott P, Dyer A, Marmot M. INTERSALT study findings : public health and medical care implications. Hypertension 1989; 14 : 570-7.
27. Xie JX, Sasaki S, Joossens JV, Kesteloot H. The relationship between urinary cations obtained from the INTERSALT study and cerebrovascular mortality. J Hum Hypertens 1992; 6: 17-21.
28. Elliott P, Stamler J, Nichols R et al. INTERSALT revisited : further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ 1996; 312 : 1249-53.
29. Wolf PA, D 'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke : a risk profile from the Framingham study. Stroke 1991; 22 : 312-8.
30. Wolf PA, D' Agostino RB, O'Neal Ma, Sytkowski P, Kase CS, Belanger AJ. Secular trends in stroke incidence and mortality : the Framingham study. Stroke 1992; 23 : 1551-5.
31. Hypertension Detection and Follow-up Program Co-operative Group. Five year findings of the hypertension detection and follow-up program. Ill-Reduction in stroke incidence among persons with high blood pressure. JAMA 1982; 247 : 633-8.
32. Abbott RD, Donahue RP, MacMohan SW, Reed DM, Yano K. Diabetes and the risk of stroke-The Honolulu heart program. JAMA 1987; 257: 949-52.
33. Dalal PM. Stroke in the diabetic patient. J Int Med 1996; 7 : 56-7.
34. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298 : 789-94.
35. Kiyohara Y, Ueda K, Hasuo Y, Fujii I. Yanai T, Wada J. Haematocrit as a risk factor of cerebral infarction : long-term prospective population survey in a Japanese rural community. Stroke 1986; 17 : 687-92.
36. Kiyohara Y, Fujishima M, Ishitsuka T, Tanaki K, Sadoshima S, Omac T. Effects of haemotocrit on brain metabolism in experimentally induced cerebral ischaemia in spontaneously hypertensive rats (SHR). Stroke 1985; 16 : 835-40.
37. Wade JPH, Taylor DW, Barnett HJM, Hachinski VC. Hemoglobin concentration and prognosis in symptomatic obstructive cerebrovascular disease. Stroke 1987; 18 : 68-71.
38. Prospective Studies Collaboration. Cholesterol,diastolic blood pressure, and stroke : 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995; 346 : 16 7-53.
39. Jha P, Flather M, Lonn E, Farkauh M, Yusuf S. The antioxidant vitamins and cardiovascular disease : a critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123 : 860-72.
40. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheaseman K, Mitchinson MJ. Randomised control led trial of vitamin E in patients with coronary disease. Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347 : 781-6.
41. Nygard O, Nordrehaug JE, Refsun H, Ureland PM, Fanstad M, Vallset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337 : 230-6.
42. Valtonen VV. Infection as a risk factor for infarction and atherosclerosis. Ann Med 1991; 25 : 539-43.
43. Capron L. Chlamydia in coronary plaques - hidden culprit or harmless hobo? Nature Med 1996; 2 : 856-7.
44. Bellavance A. For the Ticlopidine Aspirin Stroke Study Group (TASS). Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischaemic events : the ticlopidine aspirin stroke study. Stroke 1993; 24 : 1452-7.
45. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I : Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. B M J 1994; 308 : 81-106.
46. Sandercock P. For the International Stroke Trial Collaborative Group. The International stroke trial. Preliminary results Part : I : Effects of aspirin and heparin separately and in combinations (abstract) Cerebrovas Dis 1996; 6 suppl 2 : 23.
47. Wahlgren NG. Pharmacological treatment of acute stroke. Cerebrovas Dis 1997; 7 suppl 3 : 24-30.
48. National Institute of Neurological Disorder and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333 : 1581-7.
49. Donnan GA, Davis SA, Chamber BR, Gates PC, Hankey GJ, McNeill JJ et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet 1995; 345 : 578-9.
50. Multicentre Acute Stroke Trial - Italy (MAST-1). Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995; 346 : 1509-14.
51. Broderick JP, Phillips SJ, O'Fallon WM et al. Relationship of cardiac disease to stroke occurrence, recurrence and mortality. Stroke 1993; 24 : 26-30.
52. Boysen G. Anticoagulant and antiplatelet therapy in cardioembolic stroke. Cerebrovas Dis 1994; 4 : Suppl 4 : 29-33.
53. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 325 : 445-53.
54. European Carotid Surgery Trialists (ECST) Collaborative Group MRC European Surgery Trial : Interim results for symptomatic patients with severe (70-90%) or with mild (0-29%) carotid stenosis. Lancet 1991; 337 : 1235-43.
55. Toole JF. Asymptomatic carotid artery stenosis (ACAS) : diagnosis and management. Cerebrovas Dis 1994; 4 Suppl. 4 : 12-7.